首页> 外文期刊>Human Reproduction >In vitro maturation of human germinal vesicle-stage oocytes: role of epidermal growth factor-like growth factors in the culture medium.
【24h】

In vitro maturation of human germinal vesicle-stage oocytes: role of epidermal growth factor-like growth factors in the culture medium.

机译:人类生发囊泡期卵母细胞的体外成熟:表皮生长因子样生长因子在培养基中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: In vitro maturation (IVM) of oocytes is a promising technique to reduce the costs and avert the side effects of gonadotrophin stimulation for IVF. The pregnancy rates from oocytes matured in vitro are still lower than those of in vivo stimulation cycles, indicating that optimization of IVM remains a challenge. Recently, it was demonstrated that LH exerts its action on ovulation, at least in part, through stimulation of the production of the epidermal growth factor family members amphiregulin (Areg) and epiregulin (Ereg) in pre-ovulatory follicles, and they, in turn, serve as paracrine mediators of LH. We aimed to investigate the effect of supplementation of the medium with Areg and Ereg on the maturation rate of immature oocytes. METHODS: A total of 105 sibling human germinal vesicle (GV) oocytes obtained after gonadotrophin stimulation were cultured in a complex defined medium either with or without supplemented recombinant human Areg (75 ng/ml) and Ereg (75 ng/ml) for 24 h. RESULTS: Significantly more oocytes reached the metaphase II stage at 24 h in media supplemented with Areg and Ereg (75.5 versus 36.5%, P < 0.001). In vitro matured oocytes retrieved from the two subgroups had no statistically significant difference in fertilization and cleavage rates or morphology scores. Overall, a significantly higher number of Day 2 (52.8 versus 26.9% P < 0.01) and Day 3 (45.2 versus 23%, P < 0.05) embryos originated from GV oocytes cultured in the Areg- and Ereg-enriched medium. CONCLUSIONS: Supplementation of the maturation medium with Areg and Ereg improves the maturation of human GV oocytes in vitro.
机译:背景:卵母细胞的体外成熟(IVM)是一种有希望的技术,可以降低成本并避免促性腺激素刺激IVF的副作用。体外成熟的卵母细胞的妊娠率仍然低于体内刺激周期的妊娠率,这表明IVM的优化仍然是一个挑战。最近,已证明LH至少部分地通过刺激排卵前卵泡中表皮生长因子家族成员双调蛋白(Areg)和上调蛋白(Ereg)的产生发挥其排卵作用,而它们反过来又,充当LH的旁分泌介体。我们旨在研究补充Areg和Ereg的培养基对未成熟卵母细胞成熟率的影响。方法:在促性腺激素刺激后获得的总共105个同胞人类生小泡(GV)卵母细胞在含有或不含有补充重组人Areg(75 ng / ml)和Ereg(75 ng / ml)的复杂定义培养基中培养24小时。结果:在补充有Areg和Ereg的培养基中,在24 h时,进入中期II期的卵母细胞数量显着增加(75.5对36.5%,P <0.001)。从两个亚组中检索到的体外成熟卵母细胞在受精和卵裂率或形态学评分上没有统计学上的显着差异。总体而言,第2天(52.8对26.9%P <0.01)和第3天(45.2对23%,P <0.05)胚胎的数量明显多于富含Areg和Ereg的培养基中培养的GV卵母细胞。结论:用Areg和Ereg补充成熟培养基可改善人GV卵母细胞的体外成熟。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号